A 38-year-old woman with a history of alcohol use disorder presents with jaundice, hepatomegaly, and mild ascites. Liver function tests show ALT 85 U/L, AST 120 U/L, alkaline phosphatase 95 U/L, and bilirubin 3.2 mg/dL. Ultrasound abdomen shows hepatic steatosis with normal echotexture otherwise. Which investigation would be most appropriate to determine whether the hepatic injury is reversible (fatty change) or has progressed to irreversible cirrhosis?

Explanation

## Investigation for Hepatic Reversibility Assessment ### Why Liver Biopsy with Histopathology? **High-Yield:** Liver biopsy with histopathology is the gold standard for distinguishing reversible hepatic steatosis and steatohepatitis from irreversible cirrhosis. It provides direct tissue diagnosis and staging of fibrosis. **Key Point:** - **Reversible injury (hepatic steatosis/NASH):** Histology shows lipid droplets in hepatocytes ± inflammation and ballooning, but preserved hepatic architecture with no bridging fibrosis - **Irreversible injury (cirrhosis):** Histology shows bridging fibrosis, nodular regeneration, loss of normal hepatic architecture, and portal-to-portal or portal-to-central bridging ### Pathophysiologic Basis Hepatic steatosis is reversible because: 1. Lipid accumulation in hepatocytes is a metabolic derangement, not structural destruction 2. Upon removal of the offending agent (alcohol cessation), lipid is mobilized and hepatocyte function normalizes 3. Hepatic architecture and regenerative capacity remain intact Cirrhosis is irreversible because: 1. Chronic inflammation → hepatocyte necrosis → stellate cell activation 2. Progressive fibrosis → architectural distortion and loss of normal liver function 3. Once cirrhosis develops, fibrosis cannot be reversed (though progression may be halted) ### Staging Fibrosis: Ishak Score | Stage | Histology | Reversibility | |---|---|---| | **0** | No fibrosis | Fully reversible | | **1–2** | Portal fibrosis without bridging | Largely reversible | | **3–4** | Bridging fibrosis | Partially reversible | | **5–6** | Cirrhosis | Irreversible | **Clinical Pearl:** Liver biopsy is the only investigation that can definitively stage fibrosis and distinguish reversible steatohepatitis from established cirrhosis. This distinction is critical for prognosis and management (e.g., variceal screening, transplant listing). ### Comparison with Other Modalities | Investigation | Reversibility Assessment | Tissue Diagnosis | Fibrosis Staging | |---|---|---|---| | **Liver biopsy** | Excellent (gold standard) | Yes (direct histology) | Yes (Ishak/METAVIR) | | Serum albumin/PT | Indirect (synthetic function) | No | No | | Viral serology | Identifies etiology only | No | No | | Abdominal CT | Assesses cirrhotic features (ascites, varices) | No | No (indirect assessment only) | **Warning:** Elevated transaminases and ultrasound findings of steatosis do NOT distinguish reversible fatty change from cirrhosis—histology is required for definitive staging.